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The aim of this study was to investigate the clinical eﬃcacy of vanadium complexes on triglycerides (TG), total cholesterol
(Chol), uric acid (UA), urea (U), and antioxidant parameters: nonenzymatic (FRAP—ferric reducing ability of plasma, and
reduced glutathione—GSH) and enzymatic (glutathione peroxidase—GPx, catalase—CAT, and GPx/CAT ratio) activity in the
plasma of healthy male Wistar rats. Three vanadium complexes: [VO(bpy)2]SO4·2H2O, [VO(4,4′Me2bpy)2]SO4·2H2O, and
Na[VO(O2)2(bpy)]·8H2O are administered by gavage during 5 weeks in two diﬀerent diets such as control (C) and high fatty (F)
diets. Changes of biochemical and antioxidants parameters are measured in plasma. All three vanadium complexes statistically
decrease the body mass growth in comparison to the control and fatty diet. In plasma GSH was statistically increased in all
vanadium complexes-treated rats from control and fatty group in comparison to only control group. Calculated GPX/CAT ratio
was the highest in the control group in comparison to others.
1. Introduction
In physiological condition Reactive Oxygen Species (ROS)
play an important role as mediators and metabolism regu-
lators. ROS can stimulate the glucose transport to the cells,
they can be secondary messengers in the growth and death of
cells. Increase of ROS and parallel exhaustion of antioxidative
reserve is known as antioxidative stress. Various chronic dis-
eases, such as inflammatory diseases, cancer, cardiovascular
or metabolic diseases, are associated with an increased ox-
idative stress, a process characterized by an excessive for-
mation of simple, highly reactive molecules, or ROS, such
as superoxide anions, hydrogen peroxides, or peroxynitrites
[1, 2]. This is why the development of tests aimed at
determining the relativeness between the production of ROS
and the antioxidant properties in the organism has become a
clinical issue, especially since treatment with antioxidants is
suspected to have a preventive eﬀect on pathogenic processes.
Diabetes, especially type 2, is one of more common dis-
eases in highly developed countries [3, 4]. The dynamics of
development of this disease suggests that in the future more
people can have problem with glucose tolerance. As the first
step of treatment of this disease, diet and life style can be
suﬃcient but not for a long time. After this period, medical
treatment is necessary. At present, there are a lot of medica-
ments in the diabetes treatment but new molecules, which
will be more positive than the present ones, are searched for.
Usually in patients with diabetes type 2, we can observe a
lower level of natural antioxidants in blood such as ascorbic
acid, tocopherol, reduced glutathione, and uric acid [5].
From the 1980s vanadium and its compounds have been
tested as new medicaments in diabetes. For this moment
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organic complexes have more interesting properties than
the inorganic compounds. Vanadium has also the ability to
change the oxidative step in a living organism and can have
a positive or negative influence on total the oxidative defense.
This mechanism is very variable and dependent on the
oxidative step, used dose, type of ligands, presence of vitamin
C, tocopherol, and others. As oxidative stress may play a role
in the development of many diseases, diﬀerent antioxidants
are useful in their treatment. Among various antioxidants
vanadium complexes seem to be promising [6]. Vanadium
is one of the trace elements really existing for a living or-
ganism. Vanadium-organoligand complexes have been used
to examine the structure and activity of many proteins,
taking opportunity of spectroscopic techniques [7]. There
are naturally appearance ligands that bind vanadium, such
as the iron binding siderophores. Siderophores are involved
in iron homeostasis, and their binding of vanadium occurs
to be a secondary function [8]. Vanadate does inhibit the
transport of iron-siderophore complexes [9], showing that
there is an interaction of vanadium with iron transport sys-
tems. Many natural metabolites, including glutathione, cys-
teine, ascorbic acid, nucleotides, and carbohydrates, form
complexes with vanadium that have been characterized by
the diﬀerent authors in [10–12]. The interactions of vana-
dium and antioxidant like reduced glutathione or superoxide
dismutase, a particularly well-defined system, could be inti-
mately involved in the interactions of cellular vanadium and
redox properties [13]. Because oxidative stress may play role
in the development of many diseases, diﬀerent antioxidants
are useful in the treatment of them. Among the various an-
tioxidants, vanadium complexes seem to be promising [6].
In this work, the animal model with control and high
fatty diet (30% w/w of saturated fats acids) has been used
in the diabetes treatment, high fatty diet with small portion
of carbohydrates is frequently proposed. This work shows
changes in the chosen biochemical and antioxidant param-
eters (TG, Chol, UA, U, FRAP, GSH, GSHt, GPx, CAT, and
GPX/CAT ratio) in Wistar rats after vanadium complexes
administration by gavage in both the control and fatty
diet. These parameters play an important role in oxidation
defense, and it is important to study the influence of this
metal on homeostasis in tested animals.
2. Materials
2.1. Vanadium Complexes. Vanadium complexes used for
this experiment have been synthesized by Dr. R. Grybos
from the Faculty of Chemistry of Jagiellonian University
in Krakow. Bipyridine and methyl bipiperidine was used
as ligand but diﬀerences between these complexes were
associated with the oxidative step of vanadium (vanadium
IV and vanadium V). Tested complexes. In the present work,
three complexes were used: [VO(bpy)2]SO4·2H2O marked
as B, [VO(4, 4′Me2bpy)2]SO4·2H2O-marked as Bm, and
Na[VO(O2)2(bpy)]·8H2O marked as V.
2.2. Animals. The experiment was conducted on the 3-
month-old male Wistar rats, weighing 250 ± 15 g and caged
Table 1: The composition of the control diet (C) and high fat diet
(F) administered to Wistar rats.
Components Control diet (C) % High Fatty diet (F) %
Starch 62 32
Casein 20 20
Oil 5.0 5.0
Lard 0 30
Calcium carbonate 2.8 2.8
Ca3(PO4)2 2.9 2.9
Lecithin 1.0 1.0
NaCl 0.3 0.3
Cellulose 4.7 4.7
Minerals and
vitamins mix.
1.0 1.0
MgO 0.07 0.07
K2SO4 0.23 0.23
in the temperature of 23◦C, humidity 50–60%, and light-
dark cycle (12/12 h). Each group consisted of 6 animals.
During the time of the experiment, the C group was fed with
the standard diet (Table 1), while the C+V, C+B, and C+Bm
groups were fed with the standard chow with the addition of
vanadium complex V, vanadium complex B, and vanadium
complex Bm, respectively. The animals from the F group
received the highfatty diet (Table 1) The animals from the
F+V, F+B, and F+Bm groups received the fatty chow with
the addition of vanadium complex V, vanadium complex
B, and vanadium complex Bm. In all vanadium treated
groups, tested complexes were administered by gavage once
a day during 5 weeks in the dose of 20mg/kg body mass.
The experiments were performed in accordance with legal
requirements, under a license granted by the Local Commis-
sion of Ethics in Krakow. After 5 weeks of the experiment the
animals were anesthetized, and blood was collected from the
abdominal aorta. The blood was centrifuged during 15min
3000 r/min and frozen until the analysis.
3. Methods
3.1. Biochemical Analysis. Biochemical analysis was made
with the standard biochemical analyzer Alize with standard
kits (Chol, TG, UA, and U) from Biome´rieux, and it was con-
trolled with Control Serum 1, ODC0003 and Control Serum
2, ODC0004 (OLYMPUS). All the reagents were of analytical
grade and were obtained from Sigma Aldrich Chemical
Company (Steinheim, Germany).
3.2. Measurement of FRAP Activity. The FRAP method has
been used in antioxidant properties measurements. In acidic
environment, Fe3+ present in FRAP is reduced to Fe2+, pos-
sessing intensive blue colour, with maximum absorbance at
593 nm. This reaction undergoes with any substance, which
exhibits reduction properties. The FRAP is the modification
of Benzie and Strein’s [14] method. In case of the FRAP
method, the Fe2+ content in the tested samples of plasma
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Figure 1: Values of animal weight changes of animals fed with a
standard diet and high fatty diet (P ≤ 0.2005) with the addition of
vanadium complexes tested. Data presented as mean ± SD for n =
6. (b) Statistical diﬀerences between groups P < 0.05.
was calculated based on the standard curve. The FRAP con-
centration values (mM) one read for the tested substances of
15min.
3.3. Measurement of Glutathione Peroxidase (GPx) Activity.
Glutathione peroxidase GPx (EC 1.11.1.9) activity in the
rat plasma was assayed with Paglia and Valentine’s method
(Paglia and Valentine 1967), usingH2O2 andNADPH as sub-
strates. The conversion of NADPH to NADP+ was followed
by recording the changes in absorption intensity at 340 nm,
and one unit was expressed as 1 nM of NADPH consumed
per minute/mg protein
3.4. Measurement of Catalase (CAT) Activity. Catalase CAT
(EC 1.11.1.6) activity was measured with Aebi’s method [15]
and estimated in plasma. The measurements were performed
spectrophotometrically at 240 nm at 25◦C. One unit of CAT
activity was defined as the amount of enzyme decomposing
1 µmol of H2O2 per minute. CAT concentrations were ex-
pressed in U/mg of protein. Balance between antioxidant
enzymes was expressed as a ratio between glutathione per-
oxidase and catalase (GPx/CAT ratio). GPx/CAT ratio was
calculated after the measurement of catalase activity accord-
ing to Aebi’s method.
3.5. Statistical Analysis. The results in this study were
expressed as the means and standard deviations SDs. Dif-
ferences in the results between the studied subjects were
analyzed with the ANOVA test. Statistical analyses were per-
formed with STATISTICA PL software, version 8.0 (Statsoft
Pl).
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Figure 2: Eﬀects of vanadium complex V, B, and Bm on plasma of
total cholesterol of Wistar rats. Data are presented as mean± SD for
n = 6. (b) Statistical diﬀerences between groups P < 0.05.
4. Results and Discussion
The eﬀect of vanadium complexes on changes in increase
of body weight is shown in Figure 1. It was observed that
the addition of vanadium compounds to the standard diet
caused reduced weight gain. In case of complex B, weight
gain was 89.83 ± 13.8 (P = 0.0455; Figure 1(a)) and in group
Bm 86.3 ± 13.3. in comparison to control group. These
changes were statistically significant and accounted for about
25% reduction in weight gain (P = 0.0027; Figure 1(a)).
Complex V, added to the high fatty diet, also caused a
statistically significant (P = 0.0455), decreased weight gain
(92± 13.1 g) in comparison to high fatty diet. The vanadium
complexes, depending on the applied diet (diet C or diet F),
caused the reduced increase of body mass.
Figure 2 shows changes in total cholesterol levels. Vana-
dium complex B, given in the diet C, caused a reduction of
cholesterol levels by about 21%. Complex Bm added to the
diet F caused an increase of cholesterol levels by 45% (P =
0.0027; Figure 2(a)). Other groups showed no statistically
significant eﬀect on the change in cholesterol levels.
For TG levels (Figure 3), there was no significant change
in the group of animals fed with the control diet. However,
the vanadium complexes V and B added to the F diet
caused increased concentration of TG. In the F group, TG
concentration was 0.75 ± 0.3mM, while in the F+V group
1.06 ± 0.29mM and in the F+B group 1.11 ± 0.24mM.
The supply of vanadium complexes (V, B, and Bm)
caused an increase in uric acid levels (Figure 4) in animals
with control diet. Vanadium complexes V and Bm caused a
statistically significant increase in uric acid levels (P = 0.0455
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Figure 3: Eﬀects of vanadium complex V, B, and Bm on plasma
triglycerides (TG) of Wistar rats. Data are presented as mean ± SD.
for n = 6. (b) Statistical diﬀerences between groups P < 0.05.
and P = 0,0027; Figure 4(a)). In groups of animals fed with
the F diet, the addition of vanadium compounds B and Bm
caused a statistically significant increase in uric acid levels
(P = 0.0455; Figure 4(a)).
Figure 5 presents the impact of vanadium complexes on
the concentration of urea. In animals fed with the C diet, the
addition of complex V or B caused a significant increase in
the concentration of this parameter (P = 0.045; Figure 5(a)).
The influence of vanadium complexes on the total oxida-
tive potential defined by the FRAP method was presented in
Figure 6. It was observed that, in plasma in case of vanadium
complex Bm added to the C diet, a significant growth of the
FRAP value occurred in comparison to the values for the F
group receiving the same vanadium complex (P = 0.0209;
Figure 6(a)).
The results of GPx and CAT activity after vanadium
treatment are shown in Figures 7 and 8. In the presented
investigations, vanadium complexes significantly decreased
glutathione peroxidase activity in plasma in all groups except
the C+B group (Figure 7). In plasma GPx activity decreased
from 11.01 ± 1.95U/mg proteins value to 8.45 ± 1.47U/mg
proteins (P = 0.0455; Figure 7(a)) for Bm complex in the C
group and for Bm complex in the F group from 10.07 ±
1.51U/mg proteins value to 7.81 ± 2.05U/mg proteins (P =
0.0209; Figure 7(a)).
For the next enzyme catalase, we observed higher activity
in plasma for groups treated with vanadium complexes V and
B in comparison to the control group C (Figure 8). In the
control group C, catalase (CAT) has smaller activity 482 ±
57U/mg proteins than those for complex V 580 ± 73U/mg
proteins and for complex B 951 ± 65U/mg proteins. These
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Figure 4: Eﬀects of vanadium complex V, B, and Bm on plasma uric
acid of Wistar rats. Data are presented as mean ± SD for n = 6. (b)
Statistical diﬀerences between groups P < 0.05.
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Figure 5: Eﬀects of vanadium complex V, B, and Bm on plasma
urea of Wistar rats. Data are presented as mean ± SD for n = 6. (b)
Statistical diﬀerences between groups P < 0.05.
diﬀerences were also significant (P = 0.0455 and P = 0.0027;
Figure 8(a)). For the group F animals, plasma vanadium
complexes V, B, and Bm reduced the CAT activity. Very
clear response was observed in the F+Bm group where CAT
activity was reduced from 662 ± 62U/mg proteins (F group)
to 467± 9U/mg proteins. In the F+B group, the CAT activity
was decreased to 601 ± 83U/mg proteins and in the F+V
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Figure 6: Eﬀects of vanadium complex V, B, and Bm on plasma
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Figure 7: Eﬀects of vanadium complex V, B, and Bm on plasma
GPx activity of Wistar rats. Data are presented as mean ± SD for
n = 6. (b) Statistical diﬀerences between groups P < 0.05.
group to 534 ± 56U/mg proteins. Statistical significances
were also calculated (P = 0,0027; Figure 8(a)).
The changes in the relation of GPx/CAT Ratio after the
application of vanadium complexes were decreased in the
plasma in case of the control group C (Figure 9). Significant
decrease of GPx/CAT Ratio in the C group from 22.8± 4.2 to
15.6 ± 1.1 in case of complex V as well as 12.2 ± 2.6 in case
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Figure 8: Eﬀects of vanadium complex V, B, and Bm on plasma
CAT of Wistar rats. Data are presented as mean ± SD. for n = 6. (b)
Statistical diﬀerences between groups P < 0.05.
of complex B was recorded (P = 0,0027; Figure 9(a)). The
decrease of GPx/CAT ratio after the application of vanadium
complex Bm was noticed in the C group. Decreasing of
GPx/CAT ratio in plasma from 22.8 ± 4.2 to 18.2 ± 2.3 after
the application of complex Bm (P = 0,0455; Figure 9(a)) was
observed. Changes in GPx/CAT ratio were not observed in
the F group after five weeks of adding vanadium complexes
(Figure 9). The value of GPx/CAT ratio represents the ability
of plasma to dissolve the peroxide of hydrogen In the
control group the studied vanadium complexes accelerated
the dissolution of H2O2.
5. Discussion and Conclusion
Many drugs and chemicals at relatively low dosages aﬀect
the metabolism of biota by altering normal enzyme activity,
particularly by the inhibition of a specific enzyme. The eﬀects
could be negative and systemic [16].
The unique redox and spectroscopic properties result in
metal ions and their complexes having potential medicinal
applications that could be complementary to organic com-
pounds. Recent achievements in the development of metal-
based therapeutics demonstrate that this is a potentially pros-
perous area for inorganic chemistry and have stimulated
noteworthy interest in the chemical community.
Oxidative stress plays a foremost role in etiology of
several diabetic complications [17–19]. Oxidative stress in
type 2 diabetes may be the result of both antioxidant
system failure and increased production of ROS. Laboratory
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Figure 9: Eﬀects of vanadium complex V, B, and Bm on plasma
GPx/CAT ratio of Wistar rats. Data are presented as mean ± SD for
n = 6. (b) Statistical diﬀerences between groups P < 0.05.
markers for oxidative stress andmeasurement of total antiox-
idant activity of plasma are a useful tool for the qualitative
and quantitative determination of free radical events. These
parameters help to control the treatment of chronic diseases,
including type 2 diabetes [20]. Similar results of vanadium
complexes on changes in increase of body weight were
obtained by Mukherjee et al. [21]. Works of other authors
present lowering of cholesterol and TG in streptozotocin
diabetic rats but not in normal diets [22–25]. In the literature
there are no information about vanadium with fatty diets so
it is diﬃcult to discuss about obtained results.
Vanadium complex V in the F diet had no eﬀect on
changing the concentration of UA. This suggest positive ef-
fect of vanadium before oxidative stress. In animals fed with
the F diet, the addition of vanadium complexes did not cause
statistically significant changes in the concentration of urea.
Observed eﬀect in plasma can suggests influence of vana-
dium treatment on protein metabolism and must be more
examined in the future. The FRAP assay gives fast, repro-
ducible results with plasma, with single antioxidants in
pure solution and with mixtures of antioxidants in aqueous
solution and was used for calibration added to plasma. On
the basis of investigations presented by Russo et al. [26], the
relationships of vanadium probably do not cause increased
concentration of peroxides of lipids, which are natural sub-
strata of this enzyme [26–28]. In the studied animals’ plasma,
the decrease of GPx activity occurred. Therefore, it can be
assumed that the studied vanadium complexes do not cause
changes in the concentration of the peroxides of lipids.
The CAT plays a major role in the protection of plasma
from the toxic eﬀects of H2O2,and partially reduced oxygen
species. Catalase, iron-containing enzyme (oxidoreductase)
which catalyses the breakdown of H2O2 is a potentially de-
structive agent in cells [29].
In this experiment, vanadium complexes administered in
small doses showed significant influence on catalase activity.
Decreased CAT activity in plasma in the F+V, F+B, and
F+Bm groups may be due to enzyme protein oxidation as
a result of accumulation of H2O2 and other radicals. The
observed decrease in CAT activity after administration of
vanadium complexes may be related to oxidative inactivation
of enzyme protein [30].
In the F group, similarly, after addition of vanadium
complexes, the decrease of the GPx activity was observed.
However, our results are in contrast with those of GPx ac-
tivity which demonstrated that the use of vanadium complex
V in the C group lowered the level of activity of GPx enzymes
and raised the level of activity of CAT.
Mutual connection between catalase and glutathione per-
oxidase is also examined by other authors [31]. The results of
those studies were divergent. Additional parameters such as
dose, type of compound, duration, and others can influence
results. Accordingly, further investigation of the mechanism
of antioxidative defense after drug supply is required.
There are many drugs and chemicals, which are known
to have adverse or beneficial eﬀects on human enzymes and
metabolic events. Inhibition of some important enzymes,
which play a key role in a metabolic pathway, may lead to
pathologic conditions or disorders. The toxicity of relation-
ships of vanadium is generally low, dependent on the degree
of oxidation of this element (it depends on the degree the
oxidation) and the way of its application [32, 33].
Poisonings by vanadium complexes were not observed
in natural endemic conditions. However, the toxicity of
relationships of vanadium toxic eﬀects were aﬃrmed in other
studies on human subjects [34].
In concentration, the relationships of vanadium produce
symptoms of sharp poisoning, depending on the way of ap-
plication, the dose, and the time of exposure of organism to
the working of this element [35].
From the other side, vanadium and its compounds
present diﬀerent answer in comparable conditions. Change
of oxidation state or change in ligand structure has influence
on biochemical parameters and total antioxidative status.
The present study show that answer can bemore complicated
after vanadium compounds’ administration. Complexes B
and Bm of vanadium are similar in structure. Addition of
methyl group significantly has influence on GPx and catalase
activity (Figures 8 and 9).
The ability of vanadium complexes in inhibiting the lipid
from peroxidation thereby preventing the ROS generation
has restored the imbalances in the antioxidants and plasma
enzymes responsible for the cell dysfunction and destruction.
Vanadium has also the possibility to change the oxidative
step in living organism and can have positive or negative
influence on total oxidative defense. This mechanism is very
variable and dependent on oxidative step, used dose, type of
ligands and others. It suggests that the addition of other small
function groups can change organism response on tested
compound. For the better understanding of these diﬀerences,
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bigger experiment is necessary. This study is a first step in
evaluating vanadium complexes containing fatty dietary sup-
plements Although some significant diﬀerences were seen for
the vanadium complexes analyzed in this study, any related
conclusions would require additional research, including the
analysis of additional vanadium complexes, the monitoring
of products over time, and the evaluation of appropriate
vanadium complexes’ groupings.
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